4th Quarter - Report

AGILON HEALTH, INC. for AGILON HEALTH, INC.

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP) and the ACO Reach Program; Issues related to reforming physician payments and the Medicare Access and CHIP Reauthorization Act (MACRA) (PL 114-1 0); Issues related to Medicare Advantage; Issues related to H.R.5013/S.3503 - Value in Health Care Act; Issues related to the extension of Alternative Payment Model bonus payments, telehealth flexibilities, and physician reimbursement in H.R.10545 - American Relief Act of 2025 (PL 118-158); issues related to Medicare payment demonstration projects.

LobbyistCovered position, as disclosed
KATIE BOYER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3503 (118th), H.R. 5013 (118th), H.R. 10545 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.